Calyxt Appoints Dr. Travis Frey as Chief Technology Officer
May 15 2019 - 4:30PM
Business Wire
Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company,
announced today the appointment of Dr. Travis Frey as Chief
Technology Officer, effective May 20, 2019. Dr. Frey brings his
extensive knowledge in plant biology and biotechnology to a newly
created position at the Company. As CTO, Dr. Frey will be
responsible for the Research and Development team to propel product
development and its pipeline of healthier food ingredients.
“With over 15 years of agricultural industry and technology
innovation experience, Travis will be an excellent asset to
complement the Calyxt team as we grow and assess our business
needs,” said Jim Blome, Chief Executive Officer of Calyxt. “Travis
has a well-rounded background in the field, and I’m confident that
in partnership with our Chief Science Officer, Prof. Dan Voytas, he
will be a critical voice in our continuous evaluation of our food
ingredient pipeline.”
Dr. Travis Frey received his B.S. in Horticulture from Penn
State University, followed by his M.S. in Plant Breeding and Plant
Genetics from University of Wisconsin. He later obtained his Ph.D.
in the Plant Biology and Biotechnology Program at the University of
Delaware and DuPont/Pioneer and an M.B.A from the University of
Chicago – Booth School of Business. Prior to joining Calyxt, Dr.
Frey’s most recent role was with WISErg Corporation as their Vice
President of Science and Innovation, where he was responsible for
developing and championing the science and technology vision,
strategy and execution of company initiatives. Dr. Frey’s past
experience also includes various positions with Monsanto, including
Controlled Environment Facility Director, Global Dicot
Transformation Facility Director, Genome Wide Genotyping and
Platform Innovation Lead and Trait Integration Innovation Lead.
“I’m thrilled to be joining a company that uses cutting-edge
breeding techniques and forward-thinking to stay ahead of the curve
when it comes to innovation in its business,” commented Dr. Travis
Frey. “I look forward to partnering with Prof. Dan Voytas and
contributing my experience to help Calyxt remain at the forefront
of developing healthier food ingredients for consumers.”
Kincannon & Reed, a leading executive search firm focused on
the food, agribusiness, and biosciences sectors, assisted Calyxt in
the recruitment of its Chief Technology Officer.
About Calyxt
Calyxt is committed to making the food you love a healthier
choice. The care we take extends beyond nutritional value. We
partner with farmers and food companies to deliver traceable
plant-based products developed to be healthier and more sustainable
than their conventional counterparts. We use cutting edge plant
breeding techniques to develop products that help improve diets by
reducing bad fats, allergens and toxins. Today oil from our high
oleic soybean plants has lower saturated fats than commodity
soybean oil. We are also developing high fiber wheat designed to
provide an excellent source of daily fiber when incorporated into
wheat-based foods. We continuously pursue innovation to deliver
good food that is good for you.
Calyxt is located in Roseville, MN, and is listed on the Nasdaq
market (ticker: CLXT). For further information please visit our
website at www.calyxt.com.
Calyxt™ and the corporate logo are trademarks owned by Calyxt,
Inc.
Forward-Looking Statements
This communication may contain “forward-looking statements”
within the meaning of the safe harbor provisions of the U.S.
Private Securities Litigation Reform Act of 1995. In some cases,
you can identify these statements by forward-looking words such as
“may,” “might,” “will,” “should,” “expects,” “plans,”
“anticipates,” “believes,” “estimates,” “predicts,” “potential” or
“continue,” the negative of these terms and other comparable
terminology. These forward-looking statements, which are subject to
risks, uncertainties and assumptions about us, may include
projections of our future financial performance, our anticipated
growth strategies and anticipated trends in our business. These
statements are only predictions based on our current expectations
and projections about future events. There are important factors
that could cause our actual results, level of activity, performance
or achievements to differ materially from the results, level of
activity, performance or achievements expressed or implied by the
forward-looking statements, including those factors discussed under
the caption entitled “Risk Factors” in Calyxt’s Annual Report on
Form 10-K for the year ended December 31, 2018 along with other
Calyxt subsequent filings with the U.S. Securities and Exchange
Commission. We do not assume any obligation to publicly provide
revisions or updates to any forward-looking statements, whether as
a result of new information, future developments or otherwise,
should circumstances change, except as otherwise required by
applicable laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190515005953/en/
For further information, please contact:
Media contactsJennifer Moore, VP CommunicationsPhone: +1
(917) 580-1088email: media@calyxt.com
Investor Relations contactSimon Harnest, VP Corporate
Strategy and FinancePhone: +1 (646) 385-9008email:
simon.harnest@calyxt.com
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Apr 2023 to Apr 2024